Global Alcohol Addiction Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Alcohol Addiction Therapeutics

• 1.1 Definition of Alcohol Addiction Therapeutics
• 1.2 Alcohol Addiction Therapeutics Segment by Type
  • 1.2.1 Global Alcohol Addiction Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 CM-1212
  • 1.2.3 CTDP-002
  • 1.2.4 A-705253
  • 1.2.5 ABT-436
  • 1.2.6 ADX-71441
  • 1.2.7 Others
• 1.3 Alcohol Addiction Therapeutics Segment by Applications
  • 1.3.1 Global Alcohol Addiction Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Alcohol Addiction Therapeutics Overall Market
  • 1.4.1 Global Alcohol Addiction Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Alcohol Addiction Therapeutics Production (2014-2025)
  • 1.4.3 North America Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Alcohol Addiction Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Alcohol Addiction Therapeutics
• 2.3 Manufacturing Process Analysis of Alcohol Addiction Therapeutics
• 2.4 Industry Chain Structure of Alcohol Addiction Therapeutics

3 Development and Manufacturing Plants Analysis of Alcohol Addiction Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Alcohol Addiction Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Alcohol Addiction Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Alcohol Addiction Therapeutics Production and Capacity Analysis
• 4.2 Alcohol Addiction Therapeutics Revenue Analysis
• 4.3 Alcohol Addiction Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Alcohol Addiction Therapeutics Regional Market Analysis

• 5.1 Alcohol Addiction Therapeutics Production by Regions
  • 5.1.1 Global Alcohol Addiction Therapeutics Production by Regions
  • 5.1.2 Global Alcohol Addiction Therapeutics Revenue by Regions
• 5.2 Alcohol Addiction Therapeutics Consumption by Regions
• 5.3 North America Alcohol Addiction Therapeutics Market Analysis
  • 5.3.1 North America Alcohol Addiction Therapeutics Production
  • 5.3.2 North America Alcohol Addiction Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Alcohol Addiction Therapeutics Import and Export
• 5.4 Europe Alcohol Addiction Therapeutics Market Analysis
  • 5.4.1 Europe Alcohol Addiction Therapeutics Production
  • 5.4.2 Europe Alcohol Addiction Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Alcohol Addiction Therapeutics Import and Export
• 5.5 China Alcohol Addiction Therapeutics Market Analysis
  • 5.5.1 China Alcohol Addiction Therapeutics Production
  • 5.5.2 China Alcohol Addiction Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Alcohol Addiction Therapeutics Import and Export
• 5.6 Japan Alcohol Addiction Therapeutics Market Analysis
  • 5.6.1 Japan Alcohol Addiction Therapeutics Production
  • 5.6.2 Japan Alcohol Addiction Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Alcohol Addiction Therapeutics Import and Export
• 5.7 Southeast Asia Alcohol Addiction Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Alcohol Addiction Therapeutics Production
  • 5.7.2 Southeast Asia Alcohol Addiction Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Alcohol Addiction Therapeutics Import and Export
• 5.8 India Alcohol Addiction Therapeutics Market Analysis
  • 5.8.1 India Alcohol Addiction Therapeutics Production
  • 5.8.2 India Alcohol Addiction Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Alcohol Addiction Therapeutics Import and Export

6 Alcohol Addiction Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Alcohol Addiction Therapeutics Production by Type
• 6.2 Global Alcohol Addiction Therapeutics Revenue by Type
• 6.3 Alcohol Addiction Therapeutics Price by Type

7 Alcohol Addiction Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Alcohol Addiction Therapeutics Consumption by Application
• 7.2 Global Alcohol Addiction Therapeutics Consumption Market Share by Application (2014-2019)

8 Alcohol Addiction Therapeutics Major Manufacturers Analysis

• 8.1 AstraZeneca Plc
  • 8.1.1 AstraZeneca Plc Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
  • 8.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 BioCorRx Inc
  • 8.2.1 BioCorRx Inc Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.2.2 BioCorRx Inc Product Introduction, Application and Specification
  • 8.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bionex Pharmaceuticals LLC
  • 8.3.1 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.3.2 Bionex Pharmaceuticals LLC Product Introduction, Application and Specification
  • 8.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Cerecor Inc
  • 8.4.1 Cerecor Inc Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.4.2 Cerecor Inc Product Introduction, Application and Specification
  • 8.4.3 Cerecor Inc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Chronos Therapeutics Ltd
  • 8.5.1 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.5.2 Chronos Therapeutics Ltd Product Introduction, Application and Specification
  • 8.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Corcept Therapeutics Inc
  • 8.6.1 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.6.2 Corcept Therapeutics Inc Product Introduction, Application and Specification
  • 8.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Curemark LLC
  • 8.7.1 Curemark LLC Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.7.2 Curemark LLC Product Introduction, Application and Specification
  • 8.7.3 Curemark LLC Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Eli Lilly and Company
  • 8.8.1 Eli Lilly and Company Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.8.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Ethypharm SA
  • 8.9.1 Ethypharm SA Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.9.2 Ethypharm SA Product Introduction, Application and Specification
  • 8.9.3 Ethypharm SA Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 H. Lundbeck A/S
  • 8.10.1 H. Lundbeck A/S Alcohol Addiction Therapeutics Production Sites and Area Served
  • 8.10.2 H. Lundbeck A/S Product Introduction, Application and Specification
  • 8.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Heptares Therapeutics Ltd
• 8.12 Indivior Plc
• 8.13 Kinnov Therapeutics SAS
• 8.14 Kyorin Pharmaceutical Co Ltd
• 8.15 Lohocla Research Corp
• 8.16 Montisera Ltd
• 8.17 Omeros Corp
• 8.18 Opiant Pharmaceuticals Inc

9 Development Trend of Analysis of Alcohol Addiction Therapeutics Market

• 9.1 Global Alcohol Addiction Therapeutics Market Trend Analysis
  • 9.1.1 Global Alcohol Addiction Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Alcohol Addiction Therapeutics Regional Market Trend
  • 9.2.1 North America Alcohol Addiction Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Alcohol Addiction Therapeutics Forecast 2019-2025
  • 9.2.3 China Alcohol Addiction Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Alcohol Addiction Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Alcohol Addiction Therapeutics Forecast 2019-2025
  • 9.2.6 India Alcohol Addiction Therapeutics Forecast 2019-2025
• 9.3 Alcohol Addiction Therapeutics Market Trend (Product Type)
• 9.4 Alcohol Addiction Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Alcohol Addiction Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List